ctrl K

Watchlist Price Alert

Bicara Therapeutics Inc. Common Stock (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

12.92

-0.21 (-1.60%)

At close: May 09, 2025, 3:59 PM

12.97

0.39%

After-hours: May 09, 2025, 04:05 PM EDT

Bicara Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-82.39M	-69.44M	-58.34M	-49.12M	-39.89M	-26.2M	-16.67M	-8.34M
Interest Income	9.01M	4.45M	1.31M	1.31M	1.31M	13K	n/a	n/a
Pretax Income	-67.81M	-59.47M	-64.84M	-58.41M	-51.98M	-39.55M	-16.7M	-8.35M
Net Income	-68M	-59.48M	-64.84M	-58.41M	-51.98M	-39.55M	-16.7M	-8.35M
Selling & General & Admin	18.77M	15.14M	12.97M	11.12M	9.28M	6.15M	3.56M	1.78M
Research & Development	63.62M	54.3M	45.37M	37.99M	30.61M	20.05M	13.11M	6.56M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	82.39M	69.44M	58.34M	49.12M	39.89M	26.2M	16.67M	8.34M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	82.39M	69.44M	58.34M	49.12M	39.89M	26.2M	16.67M	8.34M
Income Tax Expense	187K	6K	6K	5.5K	5K	n/a	n/a	n/a
Shares Outstanding (Basic)	54.44M	54.41M	54.18M	54.18M	53.09M	54.41M	54.6M	54.6M
Shares Outstanding (Diluted)	54.44M	54.41M	54.18M	54.18M	53.09M	54.41M	54.62M	54.62M
EPS (Basic)	-1.05	-1.09	-1.19	-1.07	-0.95	-0.72	-0.3	-0.15
EPS (Diluted)	-1.05	-1.09	-1.19	-1.07	-0.95	-0.72	-0.3	-0.15
EBITDA	-82.33M	-81.47M	-70.39M	-61.18M	-51.96M	-26.2M	-16.67M	-8.33M
EBIT	-82.39M	-81.53M	-70.43M	-61.21M	-51.98M	-26.2M	-16.67M	-8.34M
Depreciation & Amortization	56K	55K	42K	30.5K	19K	5K	3K	1.5K